1) progesterone suppository
黄体酮栓剂
1.
Objective To evaluate the efficacy and safety of progesterone vaginalgel compared with progesterone suppository.
方法用随机单盲平行对照临床试验,试验组61例,对照组65例,分别于月经周期第15天开始,隔日1次分别给予黄体酮阴道凝胶和黄体酮栓剂,治疗3个月经周期。
2) Lutromone
黄体酮制剂
3) Intramuscular Progesterone
黄体酮针剂
1.
Results:There are 32 cycles vaginal bleeding,17 cycles miscarriage and 20 cycles abandoned for the hip induration and pain out of 121 cycles used Intramuscular Progesterone supplementation compared to 10 cycles vaginal bleeding,8 cycles miscarriage and no cycle abandoned the supplementation of Vaginal Progesterone in 62 cycles.
方法对比体外受精治疗中使用黄体酮针剂和安琪坦行黄体支持的阴道出血、流产率和顺应性。
4) flavonoid fraction
黄酮制剂
1.
Objective To evaluate the efficacy of micronised purified flavonoid fraction ( alvenor) to treat the ulcer of chronic venous insufficiency (CVI).
目的评价微粒化纯化的黄酮制剂(爱脉朗)治疗下肢静脉性溃疡的疗效。
5) liquid suppository
液体栓剂
1.
Effects of chitosan on the liquid suppository composed of poloxamers in vitro;
壳聚糖对泊洛沙姆液体栓剂基质影响的体外研究
2.
P407 and P188 were used as liquid suppository bases to prepare insulin liquid suppository with TMC as the absorption enhancer.
目的研究不同季铵化程度及其不同浓度的N-三甲基壳聚糖(-Ntrimethyl chitosan,TMC)对胰岛素液体栓剂体外性质的影响。
3.
P407 and P188(15/20%) were used as the base to prepare insulin liquid suppository with TMC40 or TMC60 at different concentration(0%,0.
目的研究不同季铵化程度及其不同浓度的N-三甲基壳聚糖(-Ntrimethyl chitosan,TMC)对胰岛素液体栓剂药物直肠吸收的影响。
6) suppository bases
栓剂基体
补充资料：去氢黄体酮
分子式：C21H28O2
分子量：312.45
CAS号：1096-38-4
性质：白色或类白色结晶性粉末。熔点185℃-195℃。
制备方法：由α-黄体酮脱氢分解而成。
用途：医药中间体。
分子量：312.45
CAS号：1096-38-4
性质：白色或类白色结晶性粉末。熔点185℃-195℃。
制备方法：由α-黄体酮脱氢分解而成。
用途：医药中间体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条